top of page

October 2025: Healthcare M&A Snapshot

  • Eclipse Corporate Finance
  • Nov 5
  • 3 min read
A summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in October 2025

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in October 2025 below.



Notable Sector Deals: October 2025


Narayana’s acquisition of Practice Plus Group’s hospitals


  • India-based hospital group, Narayana Health, has acquired the hospitals division of Practice Plus to enter the UK market

  • The transaction involves 12 hospitals and surgical centres across the UK, with a focus on ophthalmology, orthopaedics and general surgery

  • Narayana operates a network of primary, secondary and tertiary care facilities in India and the Caribbean

  • It intends to integrate Practice Plus into its ecosystem, leveraging its technology and operational platforms for innovation, efficiency and accessible care delivery

  • The deal follows a spate of UK hospital acquisitions, as international acquirers see growing potential in the UK’s private healthcare sector


Keensight’s investment into Bedfont Scientific


  • Keensight Capital has acquired a majority stake in Bedfont Scientific Ltd., a UK-based maker of non-invasive breath-analysis medical devices

  • Bedfont designs and manufactures high-precision breath and gas analysis instruments, including the NObreath® FeNO device (for asthma monitoring) and tools for smoking cessation and gastrointestinal disorders

  • The company distributes its products via over 100 partners in more than 70 countries and serves both primary and secondary healthcare settings globally

  • Keensight will partner with Bedfont’s management to accelerate its international expansion, drive innovation and potentially pursue further acquisitions


Acquisition of Fairford Medical’s fleet by medneo UK


  • medneo UK has acquired Fairford Medical’s MRI and CT fleet, expanding its capacity to deliver mobile and modular diagnostic imaging services

  • The deal follows CVC DIF’s investment in medneo UK in August 2024 and marks the company’s first acquisition since that partnership

  • The integration of Fairford’s fleet will broaden medneo’s national footprint, supporting the NHS with faster access to MRI and CT scans

  • The acquisition forms part of medneo’s ambitious growth strategy to become one of the UK’s leading diagnostic services providers

  • The deal highlights continued interest from strategic acquirers and investors in UK diagnostic imaging, as scan numbers continue to rise


Asker Healthcare’s acquisition of Novus Med


  • Asker Healthcare Group has acquired Novus Med, a UK-based distributor of endoscopic surgery technologies and patient-positioning systems

  • Asker Healthcare Group is a leading Nordic distributor of medical supplies and equipment, serving hospitals, care homes, and primary care providers across Europe

  • The company completed one of Europe’s largest IPOs of 2025, listing on the Stockholm Stock Exchange and raising approximately SEK 8.9 billion to support growth and acquisitions

  • The deal follows Asker’s recent acquisitions of HSL and HNC, continuing the Group’s UK expansion and acquisition drive in surgical and acute-care markets



Healthcare Market Activity: October 2025


Private Equity Activity


Sub-sector

Target

Acquirer / Investor

Exiting PE

Clinical Services

Fairford Medical’s CT/MRI fleet

medneo UK

(CVC DIF)

N/A

Clinical Services

Newry Private

Clinic

Kingsbridge

(Exponent)

N/A

Clinical Services

Practice Plus’ Hospital Division

Narayana Health

Bridgepoint

Medical Equipment

Bedfont Scientific

Keensight Capital

N/A

Specialist Care

Swanborough 

House

Integrum Care

(Duke Royalty)

N/A

Specialist Care

Victoria House

Priory Group

(Waterland)

N/A


Venture Capital Activity


Target

Description

Lead Investor

Investment

Aisthesis Medical

AI to predict in-hospital sepsis 48 hours in advance

TwinPath

TECS Capital

$1.2m

CoMind

Non-invasive brain scanning platform

Plural

$60

Cyclane Bio

Endometriosis drug

discovery

NfX

Eka VC

£5m

Gladys

AI platform to support the home care sector

Cornerstone VC

£1.5m

Jack Fertility

Accessible male fertility testing

Fuel Ventures

£500k

Simple Life

App providing practical weight loss support

HartBeat Ventures

Liquidity

£26m

Trogenix

Development of therapies for aggressive cancers

IQ Capital

£70m


 
 
 

Eclipse Corporate Finance Limited is a limited company registered in England & Wales (registered number 11791669)

The company is regulated by the Institute of Chartered Accountants of Scotland for a range of investment business activities 

  • LinkedIn
bottom of page